HEADER VIRAL PROTEIN 25-APR-21 7OC2 TITLE CRYSTAL STRUCTURE OF UNLINKED NS2B-NS3 PROTEASE FROM ZIKA VIRUS IN TITLE 2 COMPLEX WITH INHIBITOR MI-2295 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE PROTEASE SUBUNIT NS2B; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: FLAVIVIRIN PROTEASE NS2B REGULATORY SUBUNIT,NON-STRUCTURAL COMPND 5 PROTEIN 2B; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: SERINE PROTEASE NS3; COMPND 9 CHAIN: B; COMPND 10 SYNONYM: FLAVIVIRIN PROTEASE NS3 CATALYTIC SUBUNIT,NON-STRUCTURAL COMPND 11 PROTEIN 3; COMPND 12 EC: 3.4.21.91,3.6.1.15,3.6.4.13; COMPND 13 ENGINEERED: YES; COMPND 14 MOL_ID: 3; COMPND 15 MOLECULE: CYCLIC 1[2-CHLORO-4-METHOXY-PHENYL-OXYMETHYL]-4-[2,6- COMPND 16 DICHLORO-PHENYL-OXYMETHYL]-BENZENE-(7-3)-7-BENZYL-1,3-DIMETHYL-8- COMPND 17 PIPERAZIN-1-YL-3,7-DIHYDRO-PURINE-2,6-DIONE-(7-19)-N-ACETYL-L- COMPND 18 CYSTEINE-(8-25)-[3R-[3A,4A,5B(S*)]]-5-(1-CARBOXY-1-PHOSPHONOETHOXY)- COMPND 19 4-HYDROXY-3-(PHOSPHONOOXY)-1-CYCLOHEXENE-1-CARBOXYLIC ACID-()-(6E, COMPND 20 11E)-HEPTADECA-6,11-DIENE-9,9-DIYLBIS(PHOSPHONIC ACID); COMPND 21 CHAIN: D; COMPND 22 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ZIKA VIRUS; SOURCE 3 ORGANISM_COMMON: ZIKV; SOURCE 4 ORGANISM_TAXID: 64320; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: BZIPRO; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: ZIKA VIRUS; SOURCE 10 ORGANISM_COMMON: ZIKV; SOURCE 11 ORGANISM_TAXID: 64320; SOURCE 12 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 13 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 14 EXPRESSION_SYSTEM_PLASMID: BZIPRO; SOURCE 15 MOL_ID: 3; SOURCE 16 SYNTHETIC: YES; SOURCE 17 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 18 ORGANISM_TAXID: 32630 KEYWDS FLAVIVIRIN, SERINE PROTEASE, VIRAL PROTEIN, NS2B-NS3, ZIKA VIRUS EXPDTA X-RAY DIFFRACTION AUTHOR S.HUBER,A.HEINE,T.STEINMETZER REVDAT 4 31-JAN-24 7OC2 1 REMARK REVDAT 3 15-NOV-23 7OC2 1 LINK ATOM REVDAT 2 21-DEC-22 7OC2 1 JRNL REVDAT 1 06-APR-22 7OC2 0 JRNL AUTH S.HUBER,N.J.BRAUN,L.C.SCHMACKE,J.P.QUEK,R.MURRA,D.BENDER, JRNL AUTH 2 E.HILDT,D.LUO,A.HEINE,T.STEINMETZER JRNL TITL STRUCTURE-BASED OPTIMIZATION AND CHARACTERIZATION OF JRNL TITL 2 MACROCYCLIC ZIKA VIRUS NS2B-NS3 PROTEASE INHIBITORS. JRNL REF J.MED.CHEM. V. 65 6555 2022 JRNL REFN ISSN 0022-2623 JRNL PMID 35475620 JRNL DOI 10.1021/ACS.JMEDCHEM.1C01860 REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.16_3549 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.13 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.380 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 39538 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.140 REMARK 3 R VALUE (WORKING SET) : 0.139 REMARK 3 FREE R VALUE : 0.155 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1977 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 41.1300 - 3.6100 0.99 2896 152 0.1451 0.1312 REMARK 3 2 3.6100 - 2.8600 0.99 2742 144 0.1482 0.1600 REMARK 3 3 2.8600 - 2.5000 1.00 2739 144 0.1438 0.1568 REMARK 3 4 2.5000 - 2.2700 1.00 2729 144 0.1389 0.1782 REMARK 3 5 2.2700 - 2.1100 0.99 2690 142 0.1352 0.1852 REMARK 3 6 2.1100 - 1.9900 0.98 2672 140 0.1338 0.1736 REMARK 3 7 1.9900 - 1.8900 0.99 2656 140 0.1218 0.1443 REMARK 3 8 1.8900 - 1.8000 0.99 2685 141 0.1198 0.1731 REMARK 3 9 1.8000 - 1.7300 0.99 2656 140 0.1176 0.1398 REMARK 3 10 1.7300 - 1.6800 0.98 2631 139 0.1152 0.1574 REMARK 3 11 1.6800 - 1.6200 0.97 2595 136 0.1107 0.1437 REMARK 3 12 1.6200 - 1.5800 0.99 2655 140 0.1222 0.1695 REMARK 3 13 1.5800 - 1.5300 0.99 2646 139 0.1344 0.1916 REMARK 3 14 1.5300 - 1.5000 0.96 2569 136 0.1522 0.1893 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.108 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 14.718 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.11 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.55 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 1554 REMARK 3 ANGLE : 0.927 2122 REMARK 3 CHIRALITY : 0.085 235 REMARK 3 PLANARITY : 0.005 287 REMARK 3 DIHEDRAL : 20.091 571 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7OC2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 24-JUN-21. REMARK 100 THE DEPOSITION ID IS D_1292115435. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-NOV-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9184 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 39542 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 48.680 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 200 DATA REDUNDANCY : 7.970 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.03900 REMARK 200 FOR THE DATA SET : 23.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.6 REMARK 200 DATA REDUNDANCY IN SHELL : 8.07 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.48500 REMARK 200 FOR SHELL : 3.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5GPI REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.13 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M SODIUM ACETATE 0.2 M AMMONIUM REMARK 280 SULFATE 19 % PEG2000, PH 4.6, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.54050 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 41.13250 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 30.19700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 41.13250 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.54050 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 30.19700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4810 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9190 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -26.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 44 REMARK 465 THR A 45 REMARK 465 GLY A 46 REMARK 465 LYS A 47 REMARK 465 SER A 48 REMARK 465 GLU A 88 REMARK 465 GLU A 89 REMARK 465 ASP A 90 REMARK 465 GLY A 91 REMARK 465 PRO A 92 REMARK 465 PRO A 93 REMARK 465 MET A 94 REMARK 465 ARG A 95 REMARK 465 GLU A 96 REMARK 465 GLY B 0 REMARK 465 SER B 1 REMARK 465 GLY B 2 REMARK 465 ALA B 3 REMARK 465 LEU B 4 REMARK 465 TRP B 5 REMARK 465 ASP B 6 REMARK 465 VAL B 7 REMARK 465 PRO B 8 REMARK 465 ALA B 9 REMARK 465 PRO B 10 REMARK 465 LYS B 11 REMARK 465 GLU B 12 REMARK 465 VAL B 13 REMARK 465 LYS B 14 REMARK 465 LYS B 15 REMARK 465 GLY B 16 REMARK 465 GLU B 172 REMARK 465 GLU B 173 REMARK 465 THR B 174 REMARK 465 PRO B 175 REMARK 465 VAL B 176 REMARK 465 GLU B 177 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 63 NZ REMARK 470 GLU A 66 CG CD OE1 OE2 REMARK 470 ARG B 28 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 29 CG CD NE CZ NH1 NH2 REMARK 470 LEU B 30 CG CD1 CD2 REMARK 470 LEU B 31 CG CD1 CD2 REMARK 470 GLU B 62 CG CD OE1 OE2 REMARK 470 ARG B 105 CD NE CZ NH1 NH2 REMARK 470 LYS B 107 CD CE NZ REMARK 470 LYS B 117 NZ REMARK 470 LYS B 142 CG CD CE NZ REMARK 470 LYS B 157 CE NZ REMARK 470 LYS B 169 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG B 29 -104.71 -121.84 REMARK 500 LEU B 31 -143.33 -95.54 REMARK 500 TYR B 68 -53.58 -120.57 REMARK 500 ASP B 71 113.60 -161.19 REMARK 500 CYS B 80 -11.56 82.03 REMARK 500 LEU B 92 -40.95 -134.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 142 DISTANCE = 11.74 ANGSTROMS REMARK 525 HOH A 143 DISTANCE = 12.84 ANGSTROMS REMARK 525 HOH B 325 DISTANCE = 6.91 ANGSTROMS REMARK 525 HOH B 326 DISTANCE = 8.81 ANGSTROMS REMARK 525 HOH B 327 DISTANCE = 17.28 ANGSTROMS REMARK 525 HOH D 109 DISTANCE = 6.91 ANGSTROMS DBREF 7OC2 A 46 96 UNP Q32ZE1 POLG_ZIKV 1414 1464 DBREF 7OC2 B 1 177 UNP Q32ZE1 POLG_ZIKV 1499 1675 DBREF 7OC2 D 1 5 PDB 7OC2 7OC2 1 5 SEQADV 7OC2 MET A 44 UNP Q32ZE1 INITIATING METHIONINE SEQADV 7OC2 THR A 45 UNP Q32ZE1 EXPRESSION TAG SEQADV 7OC2 GLY B 0 UNP Q32ZE1 EXPRESSION TAG SEQADV 7OC2 LYS B 107 UNP Q32ZE1 ARG 1605 CONFLICT SEQRES 1 A 53 MET THR GLY LYS SER VAL ASP MET TYR ILE GLU ARG ALA SEQRES 2 A 53 GLY ASP ILE THR TRP GLU LYS ASP ALA GLU VAL THR GLY SEQRES 3 A 53 ASN SER PRO ARG LEU ASP VAL ALA LEU ASP GLU SER GLY SEQRES 4 A 53 ASP PHE SER LEU VAL GLU GLU ASP GLY PRO PRO MET ARG SEQRES 5 A 53 GLU SEQRES 1 B 178 GLY SER GLY ALA LEU TRP ASP VAL PRO ALA PRO LYS GLU SEQRES 2 B 178 VAL LYS LYS GLY GLU THR THR ASP GLY VAL TYR ARG VAL SEQRES 3 B 178 MET THR ARG ARG LEU LEU GLY SER THR GLN VAL GLY VAL SEQRES 4 B 178 GLY VAL MET GLN GLU GLY VAL PHE HIS THR MET TRP HIS SEQRES 5 B 178 VAL THR LYS GLY ALA ALA LEU ARG SER GLY GLU GLY ARG SEQRES 6 B 178 LEU ASP PRO TYR TRP GLY ASP VAL LYS GLN ASP LEU VAL SEQRES 7 B 178 SER TYR CYS GLY PRO TRP LYS LEU ASP ALA ALA TRP ASP SEQRES 8 B 178 GLY LEU SER GLU VAL GLN LEU LEU ALA VAL PRO PRO GLY SEQRES 9 B 178 GLU ARG ALA LYS ASN ILE GLN THR LEU PRO GLY ILE PHE SEQRES 10 B 178 LYS THR LYS ASP GLY ASP ILE GLY ALA VAL ALA LEU ASP SEQRES 11 B 178 TYR PRO ALA GLY THR SER GLY SER PRO ILE LEU ASP LYS SEQRES 12 B 178 CYS GLY ARG VAL ILE GLY LEU TYR GLY ASN GLY VAL VAL SEQRES 13 B 178 ILE LYS ASN GLY SER TYR VAL SER ALA ILE THR GLN GLY SEQRES 14 B 178 LYS ARG GLU GLU GLU THR PRO VAL GLU SEQRES 1 D 5 V7T DLE V8N LYS LYS HET V7T D 1 12 HET DLE D 2 8 HET V8N D 3 11 HETNAM V7T (2R)-6-AZANYL-2-CARBAMIMIDAMIDO-HEXANOIC ACID HETNAM DLE D-LEUCINE HETNAM V8N 2-[3-(AMINOMETHYL)PHENYL]ETHANOIC ACID FORMUL 3 V7T C7 H16 N4 O2 FORMUL 3 DLE C6 H13 N O2 FORMUL 3 V8N C9 H11 N O2 FORMUL 4 HOH *179(H2 O) HELIX 1 AA1 TRP B 50 LYS B 54 1 5 HELIX 2 AA2 PRO B 131 SER B 135 5 5 SHEET 1 AA1 6 ASP A 50 GLY A 57 0 SHEET 2 AA1 6 GLY B 21 ARG B 28 -1 O MET B 26 N TYR A 52 SHEET 3 AA1 6 SER B 33 GLN B 42 -1 O GLY B 37 N VAL B 25 SHEET 4 AA1 6 VAL B 45 MET B 49 -1 O VAL B 45 N GLN B 42 SHEET 5 AA1 6 LEU B 76 TYR B 79 -1 O TYR B 79 N PHE B 46 SHEET 6 AA1 6 PRO B 67 ASP B 71 -1 N TRP B 69 O SER B 78 SHEET 1 AA2 6 PHE A 84 LEU A 86 0 SHEET 2 AA2 6 ARG A 73 LEU A 78 -1 N ALA A 77 O SER A 85 SHEET 3 AA2 6 GLY B 114 THR B 118 1 O LYS B 117 N LEU A 74 SHEET 4 AA2 6 GLY B 121 VAL B 126 -1 O ILE B 123 N PHE B 116 SHEET 5 AA2 6 TYR B 161 ALA B 164 -1 O SER B 163 N VAL B 126 SHEET 6 AA2 6 GLY B 153 VAL B 155 -1 N VAL B 154 O VAL B 162 SHEET 1 AA3 2 LEU B 58 SER B 60 0 SHEET 2 AA3 2 GLY B 63 LEU B 65 -1 O LEU B 65 N LEU B 58 SHEET 1 AA4 4 LYS B 107 THR B 111 0 SHEET 2 AA4 4 VAL B 95 ALA B 99 -1 N LEU B 97 O ILE B 109 SHEET 3 AA4 4 PRO B 138 LEU B 140 -1 O LEU B 140 N GLN B 96 SHEET 4 AA4 4 VAL B 146 LEU B 149 -1 O GLY B 148 N ILE B 139 LINK C V7T D 1 N DLE D 2 1555 1555 1.34 LINK NZ V7T D 1 C LYS D 5 1555 1555 1.33 LINK C DLE D 2 N V8N D 3 1555 1555 1.33 LINK C V8N D 3 N LYS D 4 1555 1555 1.34 CRYST1 49.081 60.394 82.265 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020374 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016558 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012156 0.00000